Corient Private Wealth
FBIO icon

Corient Private Wealth’s Fortress Biotech FBIO Stock Holding History

Corient Private Wealth’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.7K Sell
14,963
-178,637
-92% -$607K ﹤0.01% 2761
2025
Q4 		$709K Buy
193,600
+98,133
+103% +$280K ﹤0.01% 2092
2025
Q3 		$353K Sell
95,467
-1,333
-1% -$3.37K ﹤0.01% 2020
2025
Q2 		$180K Hold
96,800
– – ﹤0.01% 2257
2025
Q1 		$151K Hold
96,800
– – ﹤0.01% 2117
2024
Q4 		$196K Sell
96,800
-3,526
-4% -$6.39K ﹤0.01% 2125
2024
Q3 		$145K Hold
100,326
– – ﹤0.01% 2275
2024
Q2 		$172K Sell
100,326
-5,000
-5% -$9.06K ﹤0.01% 2144
2024
Q1 		$211K Sell
105,326
-2,332
-2% -$4.64K ﹤0.01% 2078
2023
Q4 		$324K Buy
107,658
+106,325
+7,976% +$281K ﹤0.01% 1825
2023
Q3 		$5.81K Sell
1,333
-66,385
-98% -$455K ﹤0.01% 2127
2023
Q2 		$559K Buy
67,718
+6,714
+11% +$66.4K ﹤0.01% 1403
2023
Q1 		$750K Buy
61,004
+8,186
+15% +$97.5K ﹤0.01% 1206
2022
Q4 		$519K Buy
+52,818
New +$585K ﹤0.01% 1129

Other funds holding FBIO

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Corient Private Wealth's FBIO Position: Q1 2026 in Review

Corient Private Wealth reduced its Fortress Biotech (FBIO) stake by 92% in Q1 2026, selling an estimated $607K and leaving 14,963 shares worth $41.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2761.

Corient Private Wealth first reported a position in FBIO in Q4 2022 and has held it in 14 quarters since. The position peaked at $750K in Q1 2023. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

  • Corient Private Wealth held 14,963 shares of Fortress Biotech worth $41.7K as of Q1 2026.
  • Corient Private Wealth sold 178,637 Fortress Biotech shares in Q1 2026, an estimated $607K.
  • Fortress Biotech made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2761 holding.
  • Corient Private Wealth first reported a position in Fortress Biotech in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Fortress Biotech position peaked at $750K in Q1 2023.
  • 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.